Variant report

Variant	rs236465
Chromosome Location	chr6:36697507-36697508
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr6:36561511..36564084-chr6:36695779..36697652,2	K562	blood:
2	chr6:36696414..36698487-chr6:36724998..36726714,2	MCF-7	breast:
3	chr6:36645663..36650199-chr6:36694521..36699153,6	MCF-7	breast:
4	chr6:36695657..36698030-chr6:36700581..36702478,2	K562	blood:
5	chr6:36560896..36563675-chr6:36695597..36697920,2	MCF-7	breast:
6	chr6:36689656..36693910-chr6:36696758..36700115,6	K562	blood:

Variant related genes	Relation type
ENSG00000112081	Chromatin interaction
ENSG00000124762	Chromatin interaction
ENSG00000124772	Chromatin interaction

Extended variants
information (count: 11 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:1)

rs_ID	r²[population]
rs236452	0.82[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:10 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1031191	chr6:36588974-36718015	Bivalent/Poised TSS Weak transcription Enhancers Bivalent Enhancer Active TSS Strong transcription Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
2	nsv538201	chr6:36588974-36718015	Active TSS Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Genic enhancers Strong transcription Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
3	nsv1023171	chr6:36686935-36880899	Enhancers Flanking Active TSS Weak transcription Active TSS Strong transcription Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
4	nsv538202	chr6:36686935-36880899	Enhancers Weak transcription Strong transcription Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
5	nsv1033261	chr6:36687424-36837315	Weak transcription Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Strong transcription Genic enhancers Flanking Active TSS Active TSS Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	16 gene(s)	inside rSNPs	diseases
6	nsv885809	chr6:36687518-36719079	Enhancers Weak transcription Bivalent/Poised TSS Flanking Active TSS Strong transcription ZNF genes & repeats Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS	TF binding region CpG island Chromatin interactive region	6 gene(s)	inside rSNPs	diseases
7	nsv885810	chr6:36695223-36714491	Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Strong transcription Genic enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region	6 gene(s)	inside rSNPs	diseases
8	nsv885811	chr6:36695223-36719079	Weak transcription Enhancers Genic enhancers Flanking Active TSS Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region	6 gene(s)	inside rSNPs	diseases
9	nsv524053	chr6:36695223-36747406	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Bivalent/Poised TSS Active TSS Strong transcription ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region	11 gene(s)	inside rSNPs	diseases
10	nsv885812	chr6:36696904-36705684	Weak transcription Enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Strong transcription Bivalent Enhancer Bivalent/Poised TSS Genic enhancers	TF binding region CpG island Chromatin interactive region	5 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:35 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:36688400-36702200	Weak transcription	Sigmoid Colon	Sigmoid Colon
2	chr6:36689200-36702400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
3	chr6:36690400-36702600	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
4	chr6:36692600-36699000	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
5	chr6:36694000-36703000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
6	chr6:36695400-36698800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
7	chr6:36695800-36698200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
8	chr6:36695800-36698800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
9	chr6:36695800-36702600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
10	chr6:36695800-36702800	Weak transcription	Gastric	stomach
11	chr6:36696000-36698200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
12	chr6:36696000-36702600	Weak transcription	NHEK	skin
13	chr6:36696200-36698400	Weak transcription	Primary hematopoietic stem cells short term culture	blood
14	chr6:36696400-36697600	Enhancers	Skeletal Muscle Male	skeletal muscle
15	chr6:36696400-36697600	Enhancers	HUVEC	blood vessel
16	chr6:36696400-36697800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
17	chr6:36696400-36698000	Weak transcription	Primary neutrophils fromperipheralblood	blood
18	chr6:36696600-36697600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr6:36696600-36702200	Weak transcription	Primary B cells from peripheral blood	blood
20	chr6:36696800-36697800	Weak transcription	GM12878-XiMat	blood
21	chr6:36696800-36698200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
22	chr6:36696800-36698800	Weak transcription	Right Atrium	heart
23	chr6:36696800-36699400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
24	chr6:36696800-36700200	Weak transcription	Fetal Brain Male	brain
25	chr6:36696800-36702200	Weak transcription	Lung	lung
26	chr6:36696800-36702200	Weak transcription	Spleen	Spleen
27	chr6:36696800-36702200	Weak transcription	NHLF	lung
28	chr6:36697000-36698800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
29	chr6:36697000-36702200	Weak transcription	Primary B cells from cord blood	blood
30	chr6:36697200-36697600	Weak transcription	Primary monocytes fromperipheralblood	blood
31	chr6:36697200-36702400	Weak transcription	Adipose Nuclei	Adipose
32	chr6:36697200-36702400	Weak transcription	NHDF-Ad	bronchial
33	chr6:36697400-36697600	Enhancers	Skeletal Muscle Female	skeletal muscle
34	chr6:36697400-36697600	Weak transcription	Monocytes-CD14+_RO01746	blood
35	chr6:36697400-36702600	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links